Foto del docente

Fabio Piscaglia

Associate Professor

Department of Medical and Surgical Sciences

Academic discipline: MED/09 Internal Medicine

Coordinator of PhD Programme of General Medical and Services Sciences

Publications

Piscaglia F.; Benevento F.; Pecorell A.; Forgione A.; Stefanescu H., Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear, «AMERICAN JOURNAL OF GASTROENTEROLOGY», 2020, 115, pp. 145 - 146 [Comment or similar]

Piscaglia F.; Stefanini F.; Cantisani V.; Sidhu P.S.; Barr R.; Berzigotti A.; Chammas M.C.; Correas J.-M.; Dietrich C.F.; Feinstein S.; Huang P.; Jenssen C.; Jenssen C.; Kono Y.; Kudo M.; Liang P.; Lyshchik A.; Nolsoe C.; Xie X.; Tovoli F., Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic eraThe views of a panel of worldwide international experts, «ULTRASCHALL IN DER MEDIZIN», 2020, 41, pp. 228 - 236 [Scientific article]

Caputo F.; Dadduzio V.; Tovoli F.; Bertolini G.; Cabibbo G.; Cerma K.; Vivaldi C.; Faloppi L.; Rizzato M.D.; Piscaglia F.; Celsa C.; Fornaro L.; Marisi G.; Conti F.; Silvestris N.; Silletta M.; Lonardi S.; Granito A.; Stornello C.; Massa V.; Astara G.; Delcuratolo S.; Cascinu S.; Scartozzi M.; Casadei-Gardini A., The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, «PLOS ONE», 2020, 15, pp. 1 - 13 [Scientific article]

Leoni S.; Sansone V.; De Lorenzo S.; Ielasi L.; Tovoli F.; Renzulli M.; Golfieri R.; Spinelli D.; Piscaglia F., Treatment of combined hepatocellular and cholangiocarcinoma, «CANCERS», 2020, 12, pp. 794 - 809 [Scientific article]Open Access

Pettinari I.; Vukotic R.; Stefanescu H.; Pecorelli A.; Morelli M.; Grigoras C.; Sparchez Z.; Andreone P.; Piscaglia F.; Badia L.; Cappelli A.; Cescon M.; Conti F.; Cucchetti A.; Galaverni C.; Golfieri R.; Granito A.; Mosconi C.; Renzulli M.; Tame M.; Verucchi G.; Vitale G.; Bolondi L., Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis, «AMERICAN JOURNAL OF GASTROENTEROLOGY», 2019, 114, pp. 258 - 266 [Scientific article]

Baiges A.; Turon F.; Simon-Talero M.; Tasayco S.; Bueno J.; Zekrini K.; Plessier A.; Franchi-Abella S.; Guerin F.; Mukund A.; Eapen C.E.; Goel A.; Shyamkumar N.K.; Coenen S.; De Gottardi A.; Majumdar A.; Onali S.; Shukla A.; Carrilho F.J.; Nacif L.; Primignani M.; Tosetti G.; La Mura V.; Nevens F.; Witters P.; Tripathi D.; Tellez L.; Martinez J.; Alvarez-Navascues C.; Fraile Lopez M.L.; Procopet B.; Piscaglia F.; de Koning B.; Llop E.; Romero-Cristobal M.; Tjwa E.; Monescillo-Francia A.; Senzolo M.; Perez-LaFuente M.; Segarra A.; Sarin S.K.; Hernandez-Gea V.; Patch D.; Laleman W.; Hartog H.; Valla D.; Genesca J.; Garcia-Pagan J.C., Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study, «HEPATOLOGY», 2019, 71, pp. 658 - 669 [Scientific article]

Lisotti, Andrea; Piscaglia, Fabio; Fusaroli, Pietro, Contrast-enhanced harmonic endoscopic ultrasound-guided ethanol injection for a small hepatocellular carcinoma, «ENDOSCOPY», 2019, 51, pp. 317 - 318 [Scientific article]

Evans T.R.J.; Kudo M.; Finn R.S.; Han K.-H.; Cheng A.-L.; Ikeda M.; Kraljevic S.; Ren M.; Dutcus C.E.; Piscaglia F.; Sung M.W., Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (British Journal of Cancer, (2019), 121, 3, (218-221), 10.1038/s41416-019-0506-6), «BRITISH JOURNAL OF CANCER», 2019, 121, pp. 625 - 625 [Scientific article]

Sagrini E.; Iavarone M.; Stefanini F.; Tovoli F.; Vavassori S.; Maggioni M.; Renzulli M.; Salvatore V.; Stefanescu H.; Colombo M.; Bolondi L.; Piscaglia F., Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma, «UNITED EUROPEAN GASTROENTEROLOGY JOURNAL», 2019, 7, pp. 69 - 77 [Scientific article]

Tovoli F.; Casadei-Gardini A.; Benevento F.; Piscaglia F., Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019, «DIGESTIVE AND LIVER DISEASE», 2019, 51, pp. 1067 - 1073 [Scientific article]

Ielasi L.; Tovoli F.; Piscaglia F., Lenvatinib mesylate to treat hepatocellular carcinoma, «DRUGS OF TODAY», 2019, 55, pp. 305 - 313 [Scientific article]

Miksad R.A.; Ogasawara S.; Xia F.; Fellous M.; Piscaglia F., Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: The LiverT study, «BMC CANCER», 2019, 19, pp. 795 - 802 [Scientific article]Open Access

Matteo Ravaioli, Federica Odaldi, Alessandro Cucchetti, Franco Trevisani, Fabio Piscaglia, Vanessa De Pace, Valentina Rosa Bertuzzo, Flavia Neri, Rita Golfieri, Alberta Cappelli, Antonietta D’Errico, Matteo Cescon, Massimo Del Gaudio, Guido Fallani, Antonio Siniscalchi, Maria Cristina Morelli, Francesca Ciccarese, Maria Di Marco, Fabio Farinati, Edoardo Giovanni Giannini, Antonio Daniele Pinna, Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria, «SCIENTIFIC REPORTS», 2019, 9, pp. 1 - 9 [Scientific article]Open Access

Tovoli F.; Ielasi L.; Casadei-Gardini A.; Granito A.; Foschi F.G.; Rovesti G.; Negrini G.; Orsi G.; Renzulli M.; Piscaglia F., Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients, «JOURNAL OF HEPATOLOGY», 2019, 71, pp. 1175 - 1183 [Scientific article]

Fornari, Francesca; Gramantieri, Laura; Callegari, Elisa; Shankaraiah, Ram C; Piscaglia, Fabio; Negrini, Massimo; Giovannini, Catia, MicroRNAs in Animal Models of HCC, «CANCERS», 2019, 11, pp. 1 - 32 [Scientific article]Open Access